Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BI-1910 by BioInvent International for Solid Tumor: Likelihood of Approval
BI-1910 is under clinical development by BioInvent International and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
BI-1910 by BioInvent International for Non-Small Cell Lung Cancer: Likelihood of Approval
BI-1910 is under clinical development by BioInvent International and currently in Phase II for Non-Small Cell Lung Cancer. According to...
BI-1910 by BioInvent International for Hepatocellular Carcinoma: Likelihood of Approval
BI-1910 is under clinical development by BioInvent International and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase...